Chernett Jorey bought 7,500 derivative units of Starling Oncology, Inc. at $0.54 for $4.02k on Nov 9, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
10% owner
10%
Filed Nov 10, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$4,017.75Shares × reported price
Shares traded
7,500Call Option (STLN 19FEB27 $5C)
Price per share
$0.54Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
7,500Direct
Trade date
Nov 9, 2026Buy
Filed
Nov 10, 2026, 6:33 PM ET1-day reporting delay
Accession
0000921895-26-003018Code P · Transaction 397622
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Buy7,000$0.67$4,690Trade 397623
Nov 6, 2026Buy10,000$0.08$750Trade 397620
Nov 9, 2026Buy48,294$3.65$176,273.10Trade 397619
Nov 6, 2026Buy5,000$0.40$2,000Trade 397621
Nov 6, 2026Sell2,851,061$3.99−$11,375,733.39Trade 397618
6 transaction rows in this filing. Joint filers share the same rows.

STLN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
STLN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $3.38 to $5.21, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. F2: The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. F3: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.91, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. F4: The price reported in Column 8 is a weighted average price. These Call Options were purchased in multiple transactions at prices ranging from $0.4998 to $0.55, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Call Options purchased at each separate price such Call Options were purchased.